- Home
- ODFL vs TAK Comparison
ODFL vs TAK Comparison
Compare ODFL & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODFL
- TAK
- Stock Information
- Founded
- ODFL 1934
- TAK 1781
- Country
- ODFL United States
- TAK Japan
- Employees
- ODFL N/A
- TAK N/A
- Industry
- ODFL Trucking Freight/Courier Services
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- ODFL Industrials
- TAK Health Care
- Exchange
- ODFL Nasdaq
- TAK Nasdaq
- Market Cap
- ODFL 48.1B
- TAK 42.2B
- IPO Year
- ODFL 1991
- TAK N/A
- Fundamental
- Price
- ODFL $180.40
- TAK $14.07
- Analyst Decision
- ODFL Hold
- TAK
- Analyst Count
- ODFL 20
- TAK 0
- Target Price
- ODFL $205.00
- TAK N/A
- AVG Volume (30 Days)
- ODFL 1.9M
- TAK 1.8M
- Earning Date
- ODFL 02-05-2025
- TAK 01-30-2025
- Dividend Yield
- ODFL 0.62%
- TAK 3.63%
- EPS Growth
- ODFL N/A
- TAK 15.39
- EPS
- ODFL 5.48
- TAK 0.83
- Revenue
- ODFL $5,814,810,000.00
- TAK $29,124,927,177.00
- Revenue This Year
- ODFL $6.38
- TAK $7.80
- Revenue Next Year
- ODFL $9.86
- TAK $0.36
- P/E Ratio
- ODFL $32.92
- TAK $33.80
- Revenue Growth
- ODFL N/A
- TAK 9.83
- 52 Week Low
- ODFL $165.49
- TAK $12.58
- 52 Week High
- ODFL $233.26
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- ODFL 36.77
- TAK 64.16
- Support Level
- ODFL $198.68
- TAK $13.66
- Resistance Level
- ODFL $209.61
- TAK $13.97
- Average True Range (ATR)
- ODFL 6.74
- TAK 0.13
- MACD
- ODFL -0.76
- TAK 0.06
- Stochastic Oscillator
- ODFL 26.26
- TAK 96.15
About ODFL Old Dominion Freight Line Inc.
Old Dominion Freight Line is the second-largest less-than-truckload carrier in the United States, with more than 250 service centers and 11,000-plus tractors. It is one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns are head and shoulders above its peers. Strategic initiatives revolve around boosting network density through market share gains and maintaining industry-leading service (including ultralow cargo claims) via steadfast infrastructure investment.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.